Raymond James & Associates Gilead Sciences, Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 2,411,768 shares of GILD stock, worth $214 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,411,768
Previous 2,302,754 4.73%
Holding current value
$214 Million
Previous $158 Million 27.95%
% of portfolio
0.13%
Previous 0.11%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$66.59 - $83.99 $7.26 Million - $9.16 Million
109,014 Added 4.73%
2,411,768 $202 Million
Q2 2024

Jul 19, 2024
BUY
$63.15 - $72.88 $17.1 Million - $19.8 Million
271,545 Added 13.37%
2,302,754 $158 Million
Q1 2024

Apr 22, 2024
SELL
$71.58 - $87.29 $32.4 Million - $39.5 Million
-452,231 Reduced 18.21%
2,031,209 $149 Million
Q4 2023

Jan 16, 2024
BUY
$73.27 - $83.09 $11.6 Million - $13.2 Million
158,346 Added 6.81%
2,483,440 $201 Million
Q3 2023

Oct 24, 2023
BUY
$73.94 - $80.67 $20.5 Million - $22.3 Million
276,676 Added 13.51%
2,325,094 $174 Million
Q2 2023

Jul 25, 2023
SELL
$76.01 - $86.7 $24.6 Million - $28.1 Million
-323,605 Reduced 13.64%
2,048,418 $158 Million
Q1 2023

Apr 14, 2023
SELL
$77.31 - $88.08 $35.1 Million - $39.9 Million
-453,373 Reduced 16.05%
2,372,023 $197 Million
Q4 2022

Feb 08, 2023
SELL
$62.32 - $89.47 $10 Million - $14.4 Million
-160,462 Reduced 5.37%
2,825,396 $243 Million
Q3 2022

Oct 25, 2022
BUY
$59.54 - $68.01 $5.03 Million - $5.74 Million
84,400 Added 2.91%
2,985,858 $184 Million
Q2 2022

Aug 12, 2022
BUY
$57.72 - $65.01 $17 Million - $19.2 Million
295,348 Added 11.33%
2,901,458 $179 Million
Q1 2022

May 11, 2022
BUY
$57.92 - $72.58 $6.12 Million - $7.67 Million
105,652 Added 4.23%
2,606,110 $155 Million
Q4 2021

Feb 08, 2022
SELL
$64.88 - $73.64 $4.88 Million - $5.54 Million
-75,175 Reduced 2.92%
2,500,458 $182 Million
Q3 2021

Nov 02, 2021
SELL
$67.69 - $73.03 $2.48 Million - $2.68 Million
-36,645 Reduced 1.4%
2,575,633 $180 Million
Q2 2021

Aug 11, 2021
BUY
$63.47 - $69.35 $8.23 Million - $9 Million
129,741 Added 5.23%
2,612,278 $180 Million
Q1 2021

May 14, 2021
BUY
$60.0 - $68.46 $11.1 Million - $12.7 Million
185,705 Added 8.09%
2,482,537 $160 Million
Q4 2020

Feb 12, 2021
BUY
$56.65 - $64.55 $4.76 Million - $5.42 Million
83,988 Added 3.8%
2,296,832 $134 Million
Q3 2020

Nov 04, 2020
BUY
$62.1 - $78.08 $33.6 Million - $42.2 Million
540,455 Added 32.32%
2,212,844 $140 Million
Q2 2020

Jul 28, 2020
SELL
$72.34 - $84.0 $44 Million - $51.1 Million
-607,851 Reduced 26.66%
1,672,389 $129 Million
Q1 2020

Apr 21, 2020
SELL
$62.63 - $80.22 $20.7 Million - $26.5 Million
-330,677 Reduced 12.67%
2,280,240 $170 Million
Q4 2019

Feb 12, 2020
SELL
$61.62 - $67.78 $5.09 Million - $5.6 Million
-82,573 Reduced 3.07%
2,610,917 $170 Million
Q3 2019

Nov 07, 2019
BUY
$62.51 - $69.0 $105 Million - $116 Million
1,674,157 Added 164.24%
2,693,490 $171 Million
Q2 2019

Aug 06, 2019
SELL
$61.87 - $69.38 $671,289 - $752,773
-10,850 Reduced 1.05%
1,019,333 $68.9 Million
Q1 2019

May 06, 2019
BUY
$62.53 - $70.05 $9.6 Million - $10.8 Million
153,595 Added 17.52%
1,030,183 $67 Million
Q4 2018

Feb 11, 2019
SELL
$60.54 - $79.0 $2.34 Million - $3.05 Million
-38,590 Reduced 4.22%
876,588 $54.8 Million
Q3 2018

Nov 14, 2018
BUY
$71.28 - $78.92 $12 Million - $13.3 Million
167,901 Added 22.47%
915,178 $70.7 Million
Q2 2018

Aug 14, 2018
SELL
$64.88 - $75.68 $5.51 Million - $6.42 Million
-84,849 Reduced 10.2%
747,277 $52.9 Million
Q1 2018

May 14, 2018
SELL
$72.84 - $88.8 $148,520 - $181,063
-2,039 Reduced 0.24%
832,126 $62.7 Million
Q4 2017

Feb 14, 2018
SELL
$71.15 - $83.52 $9.62 Million - $11.3 Million
-135,254 Reduced 13.95%
834,165 $59.8 Million
Q3 2017

Nov 13, 2017
BUY
$72.11 - $85.47 $3.15 Million - $3.74 Million
43,700 Added 4.72%
969,419 $78.5 Million
Q2 2017

Aug 14, 2017
BUY
N/A
925,719
925,719 $65.5 Million

Others Institutions Holding GILD

# of Institutions
1,923
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email